Abstract Details

Title Pyridostigmine for Symptomatic Treatment of Weakness from Botulinum Toxin Ingestion

Topic Infectious Disease

Presentation(s) (-)

Poster/Presentation
Number 310

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Alicia Zha, MD (The Ohio State University Wexner Medical Center) PRESENTER	The institution of Dr. Zha has received research support from ��ɫ��. The institution of Dr. Zha has received research support from American Board of Psychiatry and Neurology.
Sushil S. Lakhani, MD (The Ohio State University Wexner Medical Center)	Dr. Lakhani has nothing to disclose.
Stanley J. Iyadurai, MD, PhD, FAAN (Johns Hopkins All Children's Hospital/Catalyst)	Dr. Iyadurai has received personal compensation for serving as an employee of Catalyst Pharmaceuticals. Dr. Iyadurai has received stock or an ownership interest from Catalyst Pharmaceuticals.

��ɫ����